48,453
edits
Difference between revisions of "SMARCB1-deficient renal medullary carcinoma"
Jump to navigation
Jump to search
SMARCB1-deficient renal medullary carcinoma (view source)
Revision as of 15:29, 20 September 2019
, 15:29, 20 September 2019no edit summary
(→IHC: wikify) |
|||
| (2 intermediate revisions by the same user not shown) | |||
| Line 7: | Line 7: | ||
| Micro = | | Micro = | ||
| Subtypes = | | Subtypes = | ||
| LMDDx = [[collecting duct carcinoma]], [[yolk sac tumour]], [[hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cell carcinoma]] | | LMDDx = [[collecting duct carcinoma]], [[yolk sac tumour]], [[hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cell carcinoma]], [[ALK translocation renal cell carcinoma]] | ||
| Stains = | | Stains = | ||
| IHC = INI1 -ve, vimentin +ve, EMA +ve | | IHC = INI1 -ve, vimentin +ve, EMA +ve | ||
| Line 70: | Line 70: | ||
*[[Collecting duct carcinoma]]. | *[[Collecting duct carcinoma]]. | ||
*[[Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cell carcinoma]]. | *[[Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cell carcinoma]]. | ||
*[[ALK translocation renal cell carcinoma]]. | |||
===Images=== | ===Images=== | ||
| Line 102: | Line 103: | ||
*CAM5.2 +ve. | *CAM5.2 +ve. | ||
*AE1/AE3 +ve. | *AE1/AE3 +ve. | ||
*Cyclin D1 +ve.<ref name=pmid22686875/> | |||
==See also== | ==See also== | ||